On May 13, 2025, Legend Biotech Corp reported its financial results for the first quarter ending March 31, 2025, showing a loss of $100.9 million compared to a loss of $59.8 million in the same period of 2024, with total revenue increasing to $195.1 million from $94.0 million. The company's current assets totaled $1.22 billion, and cash and cash equivalents amounted to $441.7 million at the period's end.